The usa and the rest of Europe presents an alarming situation due to the movement of the μεταδοτικότερης mutation of the new κορονοϊού, found initially in the Uk and then it has spread to twenty-two countries of the European zone. Until today, in Greece, were identified 1.667 samples positive for the British mutant strain Β117, according to the Athens news agency.

The new strain due to the increased contagion threatens to increase the number of outbreaks and burden on health systems, warns the WHO, and could progressively, as has been done in the Uk and increasingly in Denmark, to replace the other virus strains, which are in circulation in Europe, as he warned the director of the European department of the World Health Organisation Hans Κλούγκε.

In a survey in Great Britain by the Agency for Public Health (PHE), in a reference laboratory confirmed the ability of detection of the mutation B117 “Kent” (” VOC 202012/01″) in isolated samples of the mutation, the COVID-19 tests for the rapid detection of antigen of the English company Surescreen with sensitivity to high viral loads 97,1% and specificity of 99.9%. As a result, the Government of Great Britain proceeded on 8 February 2020 in the order of 20 million double antigen test (nasopharyngeal / saliva) of Surescreen that will be used as part of a comprehensive Government programme of detection of asymptomatic cases with wide application in schools, universities and workers .

The rapid test for detection of antigen of the Covid 19 of the English company Surescreen available in Greece and Cyprus by the company Newpharm A.E.

SOURCE: ANA-MPA